Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-28

Clinical Trial Update: Canadian Left Atrial Appendage Closure Study [NA]

View source ↗

Summary

Cardia Inc. reports a Canadian clinical trial on left atrial appendage closure for non-valvular atrial fibrillation; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cardia Inc. | Conditions: Left Atrial Appendage, Non-Valvular Atrial Fibrillation | NA | Status: UNKNOWN